Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (MRNA-4157) in Combination With KEYTRUDA (Pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
Express News | Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (Mrna-4157) in Combination With Keytruda® (Pembrolizumab) After Neoadjuvant Keytruda and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (Nsclc)
Merck & Co., Inc. (MRK): Among the Best Dow Stocks to Buy According to Analysts
M&A Deals Roundup: Merck, Seadrill, Kraft Heinz, Spirit Airlines and More
About 75% of Companies That Reported Earnings This Week Delivered EPS Wins-Earnings Scorecard
Earnings Preview: Merck & Co to Report Financial Results Pre-market on October 31
$Merck & Co(MRK.US)$ is scheduled to release its financial results pre-market on October 31 ET. Earnings PreviewAnalysts estimate $Merck & Co(MRK.US)$ to post revenue of USD16.51B for 2024Q3, up 3.44%
BetterInvesting Magazine Update on Merck (MRK) and Ball (BALL)
Catalyst Watch: Eyes on Tech With Apple, Amazon, Alphabet, and Meta Reporting
Merck Is Maintained at Buy by Citigroup
Merck & Co Analyst Ratings
Pfizer, Live Nation Entertainment And More On CNBC's 'Final Trades'
Express News | Citigroup: Lowered merck (MRK.N) target price from $140 to $130.
Express News | Merck & Co Inc : Citigroup Cuts Target Price to $130 From $140
The US presidential election is highly contested, with 23 Nobel Prize winners jointly endorsing Harris.
According to the latest news, 23 scholars who have won the Nobel Prize in Economics issued a joint statement on October 23rd in the usa, supporting the Democratic presidential candidate Harris, and criticizing her Republican rival Trump's economic plan, especially his proposal to impose tariffs.
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines
Merck (MRK): Patent Concerns and Earnings Forecast Cuts Impact Dow Performance
BofA Securities Maintains Merck & Co(MRK.US) With Buy Rating
This Biotech Stock Could Rocket 800%, Analyst Says -- Barrons.com
Merck & Co., Inc. (MRK) Is Attracting Investor Attention: Here Is What You Should Know
Merck Keytruda Cleared in EU for Two New Indications in Gynecologic Cancers